Invited Review
Diabetes technology: improving care, improving patient-reported outcomes and preventing complications in young people with Type 1 diabetes
P. Prahalad,
M. Tanenbaum,
K. Hood,
D. M. Maahs,
P. Prahalad
Division of Pediatric Endocrinology, Stanford University, Stanford, CA, USA
Search for more papers by this authorM. Tanenbaum
Division of Pediatric Endocrinology, Stanford University, Stanford, CA, USA
Search for more papers by this authorK. Hood
Division of Pediatric Endocrinology, Stanford University, Stanford, CA, USA
Search for more papers by this authorCorresponding Author
D. M. Maahs
Division of Pediatric Endocrinology, Stanford University, Stanford, CA, USA
Correspondence to: David M. Maahs. E-mail: [email protected]Search for more papers by this authorP. Prahalad,
M. Tanenbaum,
K. Hood,
D. M. Maahs,
P. Prahalad
Division of Pediatric Endocrinology, Stanford University, Stanford, CA, USA
Search for more papers by this authorM. Tanenbaum
Division of Pediatric Endocrinology, Stanford University, Stanford, CA, USA
Search for more papers by this authorK. Hood
Division of Pediatric Endocrinology, Stanford University, Stanford, CA, USA
Search for more papers by this authorCorresponding Author
D. M. Maahs
Division of Pediatric Endocrinology, Stanford University, Stanford, CA, USA
Correspondence to: David M. Maahs. E-mail: [email protected]Search for more papers by this authorAbstract
With the evolution of diabetes technology, those living with Type 1 diabetes are given a wider arsenal of tools with which to achieve glycaemic control and improve patient-reported outcomes. Furthermore, the use of these technologies may help reduce the risk of acute complications, such as severe hypoglycaemia and diabetic ketoacidosis, as well as long-term macro- and microvascular complications. In addition, diabetes technology can have a beneficial impact on psychosocial health by reducing the burden of diabetes. Unfortunately, diabetes goals are often unmet and people with Type 1 diabetes too frequently experience acute and long-term complications of this condition, in addition to often having less than ideal psychosocial outcomes. Increasing realization of the importance of patient-reported outcomes is leading to diabetes care delivery becoming more patient-centred. Diabetes technology in the form of medical devices, digital health and big data analytics have the potential to improve clinical care and psychosocial support, resulting in lower rates of acute and chronic complications, decreased burden of diabetes care, and improved quality of life.
References
- 1 The Diabetes Control and Complications Trial Research Group. The Effect of Intensive Treatment of Diabetes on the Development and Progression of Long-Term Complications in Insulin-Dependent Diabetes Mellitus. 1993.
- 2Brink SJ. Complications of pediatric and adolescent type 1 diabetes mellitus. Curr Diab Rep 2001; 1: 47–55.
- 3 National Institute for Health and Care Excellence (UK). Diabetes (Type 1 and Type 2) in Children and Young People: Diagnosis and Management, in Diabetes (Type 1 and Type 2) in Children and Young People: Diagnosis and Management. London: NICE, 2015.
- 4 American Diabetes Association. 12. Children and Adolescents. Diabetes Care 2017; 40(Suppl. 1): S105–S113.
- 5Donaghue KC, Wadwa RP, Dimeglio LA, Wong TY, Chiarelli F, Marcovecchio ML et al. ISPAD Clinical Practice Consensus Guidelines 2014. Microvascular and macrovascular complications in children and adolescents. Pediatr Diabetes 2014; 15(Suppl. 20): 257–269.
- 6Anderzén J, Samuelsson U, Gudbjörnsdottir S, Hanberger L, Åkesson K. Teenagers with poor metabolic control already have a higher risk of microvascular complications as young adults. J Diabetes Complications 2016; 30: 533–536.
- 7Mauras N, Mazaika P, Buckingham B, Weinzimer S, White NH, Tsalikian E et al. Longitudinal assessment of neuroanatomical and cognitive differences in young children with type 1 diabetes: association with hyperglycemia. Diabetes 2015; 64: 1770–1779.
- 8Haynes A, Hermann JM, Miller KM, Hofer SE, Jones TW, Beck RW et al. Severe hypoglycemia rates are not associated with HbA1c: a cross-sectional analysis of 3 contemporary pediatric diabetes registry databases. Pediatr Diabetes 2017; 18: 643–650.
- 9 Diabetes Complications and Control Research Group. Effect of intensive diabetes treatment on the development and progression of long-term complications in adolescents with insulin-dependent diabetes mellitus: Diabetes Control and Complications Trial. Diabetes Control and Complications Trial Research Group. J Pediatr 1994; 125: 177–188.
- 10Maahs DM, Hermann JM, Holman N, Foster NC, Kapellen TM, Allgrove J, Schatz DA et al. Rates of diabetic ketoacidosis: international comparison with 49,859 pediatric patients with type 1 diabetes from England, Wales, the U.S., Austria, and Germany. Diabetes Care 2015; 38: 1876–1882.
- 11Cengiz E, Xing D, Wong JC, Wolfsdorf JI, Haymond MW, Rewers A et al. Severe hypoglycemia and diabetic ketoacidosis among youth with type 1 diabetes in the T1D Exchange clinic registry. Pediatr Diabetes 2013; 14: 447–454.
- 12Silverstein J, Cheng P, Ruedy KJ, Kollman C, Beck RW, Klingensmith GJ et al. Depressive Symptoms in Youth With Type 1 or Type 2 Diabetes: Results of the Pediatric Diabetes Consortium Screening Assessment of Depression in Diabetes Study. Diabetes Care 2015; 38: 2341–2343.
- 13Iturralde E, Adams RN, Barley RC, Bensen R, Christofferson M, Hanes SJ et al. Implementation of Depression Screening and Global Health Assessment in Three Pediatric Subspecialty Clinics. J Adolesc Health 2017; 61: 591–598.
- 14Helgeson VS, Becker D, Escobar O, Siminerio L. Families with children with diabetes: Implications of parent stress for parent and child health. J Pediatr Psychol 2012; 37: 467–478.
- 15Johnson B, Eiser C, Young V, Brierley S, Heller S. Prevalence of depression among young people with Type 1 diabetes: a systematic review. Diabet Med 2013; 30: 99–208.
- 16Young-Hyman D, de Groot M, Hill-Briggs F, Gonzalez JS, Hood K, Peyrot M et al. Psychosocial care for people with diabetes: a position statement of the American Diabetes Association. Diabetes Care 2016; 39: 2126–2140.
- 17Hagger V, Hendrieckx C, Sturt J, Skinner TC, Speight J. Diabetes distress among adolescents with type 1 diabetes: a systematic review. Curr Diabetes Rep 2016; 16: 9.
- 18Hessler D, Fisher L, Polonsky W, Johnson N. Understanding the areas and correlates of diabetes-related distress in parents of teens with type 1 diabetes. J Pediatr Psychol 2016; 41: 750–758.
- 19Minges KE, Whittemore R, Weinzimer SA, Irwin ML, Redeker NS, Grey M. Correlates of overweight and obesity in 5529 adolescents with type 1 diabetes: The T1D Exchange Clinic Registry. Diabetes Res Clin Pract 2017; 126: 68–78.
- 20Bryden KS, Neil A, Mayou RA, Peveler RC, Fairburn CG, Dunger DB. Eating habits, body weight, and insulin misuse. A longitudinal study of teenagers and young adults with type 1 diabetes. Diabetes Care 1999; 22: 1956–1960.
- 21Jaser SS, White LE. Coping and resilience in adolescents with type 1 diabetes. Child Care Health Dev 2011; 37: 335–342.
- 22Hilliard ME, De Wit M, Wasserman RM, Butler AM, Evans M, Weissberg-Benchell J et al. Screening and support for emotional burdens of youth with type 1 diabetes: Strategies for diabetes care providers. Pediatr Diabetes 2017; https://doi.org/10.1111/pedi.12575. [Epub ahead of print].
10.1111/pedi.12575 Google Scholar
- 23Miller KM, Beck RW, Bergenstal RM, Goland RS, Haller MJ, McGill JB et al. Evidence of a strong association between frequency of self-monitoring of blood glucose and hemoglobin A1c levels in T1D exchange clinic registry participants. Diabetes Care 2013; 36: 2009–2014.
- 24Miller KM, Foster NC, Beck RW, Bergenstal RM, DuBose SN, DiMeglio LA et al. Current state of type 1 diabetes treatment in the U.S.: updated data from the T1D Exchange clinic registry. Diabetes Care 2015; 38: 971–978.
- 25Edge J, Acerini C, Campbell F, Hamilton-Shield J, Moudiotis C, Rahman S et al. An alternative sensor-based method for glucose monitoring in children and young people with diabetes. Arch Dis Child 2017; 102: 543–549.
- 26 Juvenile Diabetes Research Foundation Continuous Glucose Monitoring Study. Group. Effectiveness of continuous glucose monitoring in a clinical care environment: evidence from the Juvenile Diabetes Research Foundation continuous glucose monitoring (JDRF-CGM) trial. Diabetes Care 2010; 33: 17–22.
- 27Polonsky WH, Hessler D, Ruedy KJ. Beck RW; DIAMOND Study Group. The Impact of Continuous Glucose Monitoring on Markers of Quality of Life in Adults With Type 1 Diabetes: Further Findings From the DIAMOND Randomized Clinical Trial. Diabetes Care 2017; 40: 736–741.
- 28McKergow E, Parkin L, Barson DJ, Sharples KJ, Wheeler BJ. Demographic and regional disparities in insulin pump utilization in a setting of universal funding: a New Zealand nationwide study. Acta Diabetol 2017; 54: 63–71.
- 29Maahs DM, Hermann JM, DuBose SN, Miller KM, Heidtmann B, DiMeglio LA et al. Contrasting the clinical care and outcomes of 2,622 children with type 1 diabetes less than 6 years of age in the United States T1D Exchange and German/Austrian DPV registries. Diabetologia 2014; 57: 1578–1585.
- 30Cooper MN, O'Connell SM, Davis EA, Jones TW. A population-based study of risk factors for severe hypoglycaemia in a contemporary cohort of childhood-onset type 1 diabetes. Diabetologia 2013; 56: 2164–2170.
- 31Karges B, Schwandt A, Heidtmann B, Kordonouri O, Binder E, Schierloh U et al. Association of Insulin Pump Therapy vs Insulin Injection Therapy With Severe Hypoglycemia, Ketoacidosis, and Glycemic Control Among Children, Adolescents, and Young Adults With Type 1 Diabetes. JAMA 2017; 318: 1358–1366.
- 32Fox LA, Buckloh LM, Smith SD, Wysocki T, Mauras N. A randomized controlled trial of insulin pump therapy in young children with type 1 diabetes. Diabetes Care 2005; 28: 1277–1281.
- 33Hanas R, Lindgren F, Lindblad B. A 2-yr national population study of pediatric ketoacidosis in Sweden: predisposing conditions and insulin pump use. Pediatr Diabetes 2009; 10: 33–37.
- 34Maahs DM, Chase HP, Westfall E, Slover R, Huang S, Shin JJ et al. The effects of lowering nighttime and breakfast glucose levels with sensor-augmented pump therapy on hemoglobin A1c levels in type 1 diabetes. Diabetes Technol Ther 2014; 16: 284–291.
- 35Garg SK, Weinzimer SA, Tamborlane WV, Buckingham BA, Bode BW, Bailey TS et al. Glucose Outcomes with the In-Home Use of a Hybrid Closed-Loop Insulin Delivery System in Adolescents and Adults with Type 1 Diabetes. Diabetes Technol Ther 2017; 19: 155–163.
- 36Peyrot M, Rubin R. Treatment satisfaction in the Sensor-Augmented Pump Therapy for A1C Reduction 3 (STAR 3) trial. Diabet Med 2013; 30: 464–467.
- 37Tanenbaum ML, Iturralde E, Hanes SJ, Suttiratana SC, Ambrosino JM, Ly TT et al. Trust in closed loop systems: A qualitative study of perspectives of experienced system users. J Health Psychol 2017; https://doi.org/10.1177/1359105317718615. [Epub ahead of print].
- 38Eilander MM, de Wit M, Rotteveel J, Snoek FJ. Low Self-Confidence and Diabetes Mismanagement in Youth with Type 1 Diabetes Mediate the Relationship between Behavioral Problems and Elevated HbA1c. J Diabetes Res 2016; 2016: 3159103.
- 39Poushter J. Smartphone Ownership and Internet Usage Continues to Climb in Emerging Economies. 2016; Available at http://www.pewglobal.org/2016/02/22/smartphone-ownership-and-internet-usage-continues-to-climb-in-emerging-economies/. Last accessed 26 July 2017.
- 40Corathers SD, Kichler J, Jones NH, Houchen A, Jolly M, Morwessel N et al. Improving depression screening for adolescents with type 1 diabetes. Pediatrics 2013; 132: e1395–e1402.
- 41Levin K, Madsen JR, Petersen I, Wanscher CE, Hangaard J. Telemedicine diabetes consultations are cost-effective, and effects on essential diabetes treatment parameters are similar to conventional treatment: 7-year results from the Svendborg Telemedicine Diabetes Project. J Diabetes Sci Technol 2013; 7: 587–595.
- 42Bouchonville MF, Paul MM, Billings J, Kirk JB, Arora S. Taking Telemedicine to the Next Level in Diabetes Population Management: a Review of the Endo ECHO Model. Curr Diab Rep 2016; 16: 96.
- 43Gräsbeck TC, Gräsbeck SV, Miettinen PJ, Summanen PA. Fundus Photography as a Screening Method for Diabetic Retinopathy in Children With Type 1 Diabetes: Outcome of the Initial Photography. Am J Ophthalmol 2016; 169: 227–234.
- 44Gulshan V, Peng L, Coram M, Stumpe MC, Wu D, Narayanaswamy A et al. Development and Validation of a Deep Learning Algorithm for Detection of Diabetic Retinopathy in Retinal Fundus Photographs. JAMA 2016; 316: 2402–2410.
- 45Harris MA, Wagner DV, Heywood M, Hoehn D, Bahia H, Spiro K. Youth repeatedly hospitalized for DKA: proof of concept for novel interventions in children's healthcare (NICH). Diabetes Care 2014; 37: e125–e126.
- 46Mayer-Davis EJ, Seid M, Crandell J, Dolan L, Lagarde WH, Letourneau L et al. Flexible Lifestyles for Youth (FL3X) behavioural intervention for at-risk adolescents with Type 1 diabetes: a randomized pilot and feasibility trial. Diabet Med 2015; 32: 829–833.
- 47Raymond JK, Berget CL, Driscoll KA, Ketchum K, Cain C, Fred Thomas JF. CoYoT1 Clinic: innovative telemedicine care model for young adults with type 1 diabetes. Diabetes Technol Ther 2016; 18: 385–390.
- 48 Medtronic, Medtronic Announces First Live Experience of Sugar.IQ with Watson for People Living with Diabetes. 2016.
- 49Peterson A, Hanberger L, Akesson K, Bojestig M, Andersson Gäre B, Samuelsson U. Improved results in paediatric diabetes care using a quality registry in an improvement collaborative: a case study in Sweden. PLoS One 2014; 9: e97875.
- 50Borg S, Palaszewski B, Gerdtham UG, Fredrik O, Roos P, Gudbjörnsdottir S. Patient-reported outcome measures and risk factors in a quality registry: a basis for more patient-centered diabetes care in Sweden. Int J Environ Res Public Health 2014; 11: 12223–12246.
- 51Dabelea D, Stafford JM, Mayer-Davis EJ, D'Agostino R Jr, Dolan L, Imperatore G et al. Association of Type 1 Diabetes vs Type 2 Diabetes Diagnosed During Childhood and Adolescence With Complications During Teenage Years and Young Adulthood. JAMA 2017; 317: 825–835.
- 52Kershnar AK, Daniels SR, Imperatore G, Palla SL, Petitti DB, Pettitt DJ et al. Lipid abnormalities are prevalent in youth with type 1 and type 2 diabetes: the SEARCH for Diabetes in Youth Study. J Pediatr 2006; 149: 314–319.
- 53Sherr JL, Hermann JM, Campbell F, Foster NC, Hofer SE, Allgrove J et al. Use of insulin pump therapy in children and adolescents with type 1 diabetes and its impact on metabolic control: comparison of results from three large, transatlantic paediatric registries. Diabetologia 2016; 59: 87–91.
- 54Witsch M, Kosteria I, Kordonouri O, Alonso G, Archinkova M, Besancon S et al. Possibilities and challenges of a large international benchmarking in pediatric diabetology-The SWEET experience. Pediatr Diabetes 2016; 17(Suppl 23): 7–15.
- 55McKnight JA, Wild SH, Lamb MJ, Cooper MN, Jones TW, Davis EA et al. Glycaemic control of Type 1 diabetes in clinical practice early in the 21st century: an international comparison. Diabet Med 2015; 32: 1036–1050.
- 56Bohn B, Rosenbauer J, Icks A, Vogel C, Beyer P, Rütschle H et al. Regional Disparities in Diabetes Care for Pediatric Patients with Type 1 Diabetes. A Cross-sectional DPV Multicenter Analysis of 24,928 German Children and Adolescents. Exp Clin Endocrinol Diabetes 2016; 124: 111–119.
- 57Karges B, Rosenbauer J, Holterhus PM, Beyer P, Seithe H, Vogel C et al. Hospital admission for diabetic ketoacidosis or severe hypoglycemia in 31,330 young patients with type 1 diabetes. Eur J Endocrinol 2015; 173: 341–350.
Citing Literature
